| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 10/24/2013 | US20130281674 Methods of Diagnosing or Treating Prostate Cancer Using The ERG Gene, Alone or in Combination with Other Over or Under Expressed Genes in Prostate Cancer |
| 10/24/2013 | US20130281673 Antibodies that bind cell-associated ca 125/o772p |
| 10/24/2013 | US20130281355 Cell culture compositions and methods for polypeptide production |
| 10/24/2013 | US20130281309 Novel biomarker for non-alcoholic fatty liver disease, and method for detecting non-alcoholic fatty liver disease by using the biomarker |
| 10/24/2013 | US20130280759 Novel antigen associated with the neovasculature of tumour metastases |
| 10/24/2013 | US20130280740 Methods for Detecting Symmetrical Dimethylarginine |
| 10/24/2013 | US20130280736 Reagents and methods for diagnosing conditions associated with hydroxylated hif 1-alpha |
| 10/24/2013 | US20130280735 Gene Expression Control DNA Element and Associated Protein |
| 10/24/2013 | US20130280286 Medicament for lct poisoning |
| 10/24/2013 | US20130280285 Chimeric antigen receptors with an optimized hinge region |
| 10/24/2013 | US20130280281 Short and d-amino acid-containing polypeptides for therapeutic conjugates and uses thereof |
| 10/24/2013 | US20130280280 Antigen binding proteins |
| 10/24/2013 | US20130280278 Anti-vegfr-3 antibody compositions |
| 10/24/2013 | US20130280277 Notch1 receptor binding agents and methods of use thereof |
| 10/24/2013 | US20130280275 Anti-ox40 antibodies and methods of using the same |
| 10/24/2013 | US20130280273 Modulation of the Activity and Differentiation of Cells Expressing the Osteoclast-Associated Receptor |
| 10/24/2013 | US20130280268 Oxidative stress responsive apoptosis inducing protein eif5a |
| 10/24/2013 | US20130280266 Antibodies to il-6 and their uses |
| 10/24/2013 | US20130280263 Toll-Like Receptor 3 Antagonists |
| 10/24/2013 | US20130280260 Osteoclastogenesis inhibitor containing anti-vdac antibody |
| 10/24/2013 | US20130280259 Use of antibodies against nk1, nk2 and/or nk3 receptors in cancer treatment |
| 10/24/2013 | US20130280258 Prognostic, diagnostic, and cancer therapeutic uses of fanci and fanci modulating agents |
| 10/24/2013 | US20130280257 Novel antibodies inhibiting c-met dimerization, and uses thereof |
| 10/24/2013 | US20130280256 Anti-baff-anti-il-17 bispecific antibodies |
| 10/24/2013 | US20130280253 Il-1 binding proteins |
| 10/24/2013 | US20130280251 Stabilized Angiopoietin-2 Antibodies And Uses Thereof |
| 10/24/2013 | US20130280249 Directed Engagement Of Activating Fc Receptors |
| 10/24/2013 | US20130280248 Method of stabilizing antibody and stabilized solution-type antibody preparation |
| 10/24/2013 | US20130280246 Humanized Antibodies with Anti-Tumor Activity |
| 10/24/2013 | US20130280244 Compositions and methods for treating neoplasia |
| 10/24/2013 | US20130280240 Materials and Methods for Improved Immunoglycoproteins |
| 10/24/2013 | US20130280166 Identification of tumor-associated cell surface antigens for diagnosis and therapy |
| 10/24/2013 | US20130280163 Antibodies and molecules derived therefrom that bind to STEAP-1 proteins |
| 10/23/2013 | EP2653540A1 Protein production method |
| 10/23/2013 | EP2653478A1 A novel antigen associated with the neovasculature of tumour metastases |
| 10/23/2013 | EP2651979A1 Human anti-sod1 antibodies |
| 10/23/2013 | EP2651978A1 Use of an antibody directed against a membrane protein |
| 10/23/2013 | EP2651977A2 Anti-notch1 antibodies |
| 10/23/2013 | EP2651976A1 Combination therapy of an afucosylated cd20 antibody with a mdm2 inhibitor |
| 10/23/2013 | EP2651975A1 Human monoclonal antibody with specificity for dengue virus serotype 1 e protein and uses thereof |
| 10/23/2013 | EP2651970A1 Serum amyloid p protein |
| 10/23/2013 | EP2651441A1 Anti-cd277 antibodies and uses thereof |
| 10/23/2013 | EP2651440A1 Cd89 activation in therapy |
| 10/23/2013 | CN103370620A Diagnostic drug and diagnostic method for alzheimer's disease |
| 10/23/2013 | CN103370337A Methods of generating antibodies to metalloenzymes |
| 10/23/2013 | CN103370336A Recombinant antibodies to the vascular endothelial growth factor (VEGF) which are obtained by means of mutagenesis of variable regions |
| 10/23/2013 | CN103370335A Novel biomarkers of liver cancer |
| 10/23/2013 | CN103361742A Human agkistrodon acutus venom immune ScFv antibody library and construction method thereof |
| 10/23/2013 | CN103361364A Eimeria tenella eIF3d gene and application thereof |
| 10/23/2013 | CN103360496A Anti-EphB4 antibodies and methods of using these antibodies |
| 10/23/2013 | CN103360495A SP35 antibodies and uses thereof |
| 10/23/2013 | CN103360494A Completely anti-CD20 human monoclonal antibody and application thereof |
| 10/23/2013 | CN103360493A Cross-reactive and bispecific anti-IL 17A/F antibodies |
| 10/23/2013 | CN103360492A Anti-ILT7 antibody |
| 10/23/2013 | CN103360491A Anti-helicobacter pylori FlaA protein antibody IgY, preparation method and application thereof |
| 10/23/2013 | CN103360489A Method for synthesizing acid-orange II artificial antigen and method for preparing acid-orange II IgY antibody |
| 10/23/2013 | CN103360483A Recombinant allergen with reduced IgE binding but undiminished T-cell antigenicity |
| 10/23/2013 | CN103360468A Preparation method for SCD1 polypeptide and anti-goose SCD1 polypeptide polyclonal antibody |
| 10/23/2013 | CN103360461A Human IL-12 affinity purification chromatographic column and preparation method thereof, and method for purifying recombinant human IL-12 by virtue of the same |
| 10/23/2013 | CN103360335A Furazolidone metabolite hapten, as well as preparation method and application thereof |
| 10/23/2013 | CN103360328A Desoxyquinocetone hapten, and preparation method and application thereof |
| 10/23/2013 | CN103360321A Nitrofurantoin metabolite hapten as well as preparation method and application thereof |
| 10/23/2013 | CN103360271A Methadone hapten, preparation method of methadone hapten, methadone antigen, methadone monoclonal antibody and application of methadone monoclonal antibody |
| 10/23/2013 | CN102718866B Method for preparing takifugu obscurus source resistant pathogenic aeromonas veronii egg-yolk antibody |
| 10/23/2013 | CN102443063B Anti-TNFalpha humanized Fab, humanized antibody and its application |
| 10/23/2013 | CN102277334B Monoclonal antibody resisting human protein RN181, as well as hybridoma cell line 3953 and kit |
| 10/23/2013 | CN102268409B Monoclonal antibody against human protein RN181 and hybridoma cell strain 3952 and kit |
| 10/23/2013 | CN101993490B Antibody combined with tubercle bacillus bacteriophage tail protein as well as preparation method and application thereof |
| 10/23/2013 | CN101646690B Antibodies to il-17a |
| 10/23/2013 | CN101346397B Agents that bind target in pulmonary tissue for treating respiratory diseases |
| 10/22/2013 | USRE44558 Chromatographic method for high yield purification and viral inactivation of antibodies |
| 10/22/2013 | US8563713 Antibodies specific to carbamazepine |
| 10/22/2013 | US8563700 Synergistic effects |
| 10/22/2013 | US8563699 Anthrax and small Pox replikins and methods of use |
| 10/22/2013 | US8563698 Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9) |
| 10/22/2013 | US8563697 Anti-IL-12/IL-23 antibodies |
| 10/22/2013 | US8563696 Antibody specifically binding to c-Met |
| 10/22/2013 | US8563695 Antibodies that bind β2 |
| 10/22/2013 | US8563694 Fully human antibodies to BTLA |
| 10/22/2013 | US8563692 Interferon-antibody fusion proteins demonstrating potent apoptotic and anti-tumor activities |
| 10/22/2013 | US8563515 Tight junction protein modulators and uses thereof |
| 10/22/2013 | US8563514 Peptides and pharmaceutical compositions for treating connective tissue |
| 10/22/2013 | US8563327 Diagnostic marker for type 1 diabetes mellitus |
| 10/22/2013 | US8563271 Antibodies specific for sclerostin and methods for increasing bone mineralization |
| 10/22/2013 | US8563269 Modified antibody compositions, methods of making and using thereof |
| 10/22/2013 | US8563249 Receptor gene screening for detecting or diagnosing cancer |
| 10/22/2013 | US8563081 Nanoparticle chains by direct bonding of functional groups and preparation thereof |
| 10/22/2013 | US8563003 Method for the treatment of malignant and infectious chronic diseases |
| 10/22/2013 | US8562995 Neoplasm specific antibodies and uses thereof |
| 10/22/2013 | US8562994 Human-murine chimeric antibodies against respiratory syncytial virus |
| 10/22/2013 | US8562992 Immunoglobulin variants and uses thereof |
| 10/22/2013 | US8562990 Method of treating psoriatic arthritis with an IL-6 receptor antibody |
| 10/22/2013 | US8562989 Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer |
| 10/22/2013 | US8562988 Strategies for improved cancer vaccines |
| 10/22/2013 | US8562985 Antibodies to c-Met |
| 10/22/2013 | US8562984 Methods of treatment using anti-IL-20 antibodies |
| 10/22/2013 | US8562977 Human aminoacyl-tRNA synthetase polypeptides useful for the regulation of angiogenesis |
| 10/22/2013 | CA2580981C Stabilized human igg4 antibodies |
| 10/22/2013 | CA2526720C Recombinant carrier molecule for expression, delivery and purification of target polypeptides |
| 10/22/2013 | CA2522957C Compositions and methods for the therapy of inflammatory bowel disease |